These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 852589)

  • 21. [Action of various iodinated phenolic products on swine renal DOPA decarboxylase].
    Michel R; Truchot R; Rosner B
    C R Seances Soc Biol Fil; 1966; 160(6):1163-6. PubMed ID: 4225957
    [No Abstract]   [Full Text] [Related]  

  • 22. Affinity labeling of pig kidney 3,4-dihydroxyphenylalanine (Dopa) decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active-site cysteine.
    Dominici P; Maras B; Mei G; Borri Voltattorni C
    Eur J Biochem; 1991 Oct; 201(2):393-7. PubMed ID: 1935936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
    Colamartino M; Padua L; Meneghini C; Leone S; Cornetta T; Testa A; Cozzi R
    DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
    Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substrate specificity and other properties of DOPA decarboxylase from guinea pig kidneys.
    Srinivasan K; Awapara J
    Biochim Biophys Acta; 1978 Oct; 526(2):597-604. PubMed ID: 309771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase.
    Dominici P; Moore PS; Borri Voltattorni C
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):493-500. PubMed ID: 8240248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M; Nakawatase C; Kovathana N; Frohman LA
    Neuroendocrinology; 1977; 24(1):24-34. PubMed ID: 600362
    [No Abstract]   [Full Text] [Related]  

  • 28. Preliminary X-ray analysis of a new crystal form of recombinant pig kidney DOPA decarboxylase.
    Malashkevich VN; Burkhard P; Dominici P; Moore PS; Borri Voltattorni C; Jansonius JN
    Acta Crystallogr D Biol Crystallogr; 1999 Feb; 55(Pt 2):568-70. PubMed ID: 10089382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of 3,4-dihydroxyphenylalanine decarboxyase from pig kidney.
    Voltattorni CB; Minelli A; Vecchini P; Fiori A; Turano C
    Eur J Biochem; 1979 Jan; 93(1):181-8. PubMed ID: 436828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine).
    Christenson JG; Dairman W; Udenfriend S
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):343-7. PubMed ID: 4536745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The origin of blood k-hydroxyindoleacetic acid following L-hydrazino-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
    Wurtman RJ; Watkins CJ
    Nature; 1977 Jan; 265(5589):79-80. PubMed ID: 834247
    [No Abstract]   [Full Text] [Related]  

  • 34. Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases.
    Maras B; Dominici P; Barra D; Bossa F; Voltattorni CB
    Eur J Biochem; 1991 Oct; 201(2):385-91. PubMed ID: 1935935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.
    Dominici P; Moore PS; Castellani S; Bertoldi M; Voltattorni CB
    Protein Sci; 1997 Sep; 6(9):2007-15. PubMed ID: 9300500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reaction of pyridoxal phosphate with holoenzymes in the pyridoxamine phosphate form.
    Minelli A; Borri Voltattorni C; Grant P; Basford JM; John RA
    Prog Clin Biol Res; 1984; 144A():289-94. PubMed ID: 6374674
    [No Abstract]   [Full Text] [Related]  

  • 37. Substrate specificity of aromatic-L-amino adid decarboxylase.
    Bosin TR; Buckpitt AR; Maickel RP
    Life Sci; 1974 Mar; 14(5):899-908. PubMed ID: 4828405
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA.
    PORTER CC; WATSON LS; TITUS DC; TOTARO JA; BYER SS
    Biochem Pharmacol; 1962 Nov; 11():1067-77. PubMed ID: 13972347
    [No Abstract]   [Full Text] [Related]  

  • 39. Some immunochemical properties of pig kidney DOPA decarboxylase.
    Rosei MA; Citro G; D'Erme M; Finazzi-Agrò A
    Immunol Commun; 1984; 13(4):381-9. PubMed ID: 6434407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.